Viewing Study NCT01055795


Ignite Creation Date: 2025-12-24 @ 1:33 PM
Ignite Modification Date: 2025-12-29 @ 5:32 PM
Study NCT ID: NCT01055795
Status: COMPLETED
Last Update Posted: 2012-12-24
First Post: 2010-01-24
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Safety Study of Bevacizumab, Everolimus and LBH589 (BEL) for Advanced Solid Tumors
Sponsor: Herbert Hurwitz
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module